RCAG
GENE

Rehmann Capital Advisory Group’s Genetic Technologies Ltd. GENE Stock Holding History

Rehmann Capital Advisory Group’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$70 Buy
+7
New +$78 ﹤0.01% 1676

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Rehmann Capital Advisory Group's GENE Position: Q3 2019 in Review

Rehmann Capital Advisory Group opened a new position in Genetic Technologies Ltd. (GENE) in Q3 2019: 7 shares worth $70. The stake represents ﹤0.01% of the portfolio and ranks #1676 among its holdings.

6 funds tracked by Wall St. Rank hold GENE as of Q3 2019.

  • Rehmann Capital Advisory Group held 7 shares of Genetic Technologies Ltd. worth $70 as of Q3 2019.
  • Genetic Technologies Ltd. was a new Rehmann Capital Advisory Group position in Q3 2019.
  • Genetic Technologies Ltd. made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1676 holding.
  • 6 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.